{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:42:32Z","timestamp":1791668552498,"version":"4.3.4"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010888","name":"Wuhan Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023020201020510"],"award-info":[{"award-number":["2023020201020510"]}],"id":[{"id":"10.13039\/501100010888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042025YXB027"],"award-info":[{"award-number":["2042025YXB027"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","award":["XKJS202005"],"award-info":[{"award-number":["XKJS202005"]}],"id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006765","name":"Chinese Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017958","name":"Health Commission of Hubei Province","doi-asserted-by":"publisher","award":["WJ2023M068"],"award-info":[{"award-number":["WJ2023M068"]}],"id":[{"id":"10.13039\/100017958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013807","name":"Wuhan University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016359","name":"Wuhan University Zhongnan Hospital","doi-asserted-by":"publisher","award":["ZNJC202322"],"award-info":[{"award-number":["ZNJC202322"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016359","name":"Wuhan University Zhongnan Hospital","doi-asserted-by":"publisher","award":["2025LCYJZX-MS009"],"award-info":[{"award-number":["2025LCYJZX-MS009"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016359","name":"Wuhan University Zhongnan Hospital","doi-asserted-by":"publisher","award":["2025LCYJZX-ZD005"],"award-info":[{"award-number":["2025LCYJZX-ZD005"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016359","name":"Wuhan University Zhongnan Hospital","doi-asserted-by":"publisher","award":["ZNQNJC2022003"],"award-info":[{"award-number":["ZNQNJC2022003"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105415","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:40:11Z","timestamp":1780443611000},"page":"105415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential"],"prefix":"10.1016","volume":"225","author":[{"given":"Ruihan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-si","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-lin","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105415_bib1","first-page":"749","article-title":"Folated-nanocarrier for paclitaxel drug delivery in leukemia cancer therapy","volume":"10","author":"Al-Musawi","year":"2018","journal-title":"J. Pharm. Sci. Res."},{"key":"10.1016\/j.critrevonc.2026.105415_bib2","doi-asserted-by":"crossref","unstructured":"Alnasraui, A.H.F., Al-Musawi, S., 2022. Nanoformulation of intelligence polymeric nanocarrier for resveratrol targeted delivery and study its cytotoxic, apoptotic, and genetics effects in epidermoid carcinoma therapy. AIP Conference Proceedings 2437, 020030. \u3008https:\/\/doi.org\/10.1063\/5.0092330\u3009.","DOI":"10.1063\/5.0092330"},{"key":"10.1016\/j.critrevonc.2026.105415_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105415_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113365","article-title":"A comprehensive review of immune checkpoint inhibitors for cancer treatment","volume":"143","author":"Arafat Hossain","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41467-021-22311-z","article-title":"Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors","volume":"12","author":"Bahmani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105415_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202506791","article-title":"Developing a personalized cancer nanovaccine using coxsackievirus-reprogrammed cancer cell membranes for enhanced anti-tumor immunity","volume":"12","author":"Bahreyni","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105415_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105415_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/IJN.S346685","article-title":"Hybrid cell membrane-functionalized biomimetic nanoparticles for targeted therapy of osteosarcoma","volume":"17","author":"Cai","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.critrevonc.2026.105415_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1208\/s12249-023-02594-9","article-title":"Photothermal therapy mediated hybrid membrane derived nano-formulation for enhanced cancer therapy","volume":"24","author":"Cao","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.critrevonc.2026.105415_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122456","article-title":"Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis","volume":"305","author":"Chen","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105415_bib12","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1021\/acsnano.6b04695","article-title":"Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy","volume":"10","author":"Chen","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5483\/BMBRep.2023-0024","article-title":"Immunogenic cell death in cancer immunotherapy","volume":"56","author":"Choi","year":"2023","journal-title":"BMB Rep."},{"key":"10.1016\/j.critrevonc.2026.105415_bib14","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1021\/acsnano.8b02446","article-title":"M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors","volume":"12","author":"Choo","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib15","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1412420111","article-title":"Clearance of pathological antibodies using biomimetic nanoparticles","volume":"111","author":"Copp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105415_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","article-title":"Cell membrane coated nanocarriers \u2013 an efficient biomimetic platform for targeted therapy","volume":"327","author":"Dash","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105415_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.cclet.2019.10.040","article-title":"NIR light-induced tumor phototherapy using ICG delivery system based on platelet-membrane-camouflaged hollow bismuth selenide nanoparticles","volume":"31","author":"Ding","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.critrevonc.2026.105415_bib19","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3389\/fimmu.2019.01590","article-title":"The human platelet as an innate immune cell: interactions between activated platelets and the complement system","volume":"10","author":"Eriksson","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib22","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/adma.201300638","article-title":"Surface functionalization of gold nanoparticles with red blood cell membranes","volume":"25","author":"Gao","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fimmu.2015.00588","article-title":"Molecular and translational classifications of DAMPs in immunogenic cell death","volume":"6","author":"Garg","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12951-020-00649-8","article-title":"Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy","volume":"18","author":"Gong","year":"2020","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105415_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12951-021-00805-8","article-title":"Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles","volume":"19","author":"Gong","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105415_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404184","article-title":"Hybrid cell membrane-coated nanoparticles for synergizing sonodynamic therapy and immunotherapy against triple-negative breast cancer","volume":"14","author":"Gong","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2022.01.004","article-title":"Biomimetic platelet membrane-coated nanoparticles for targeted therapy","volume":"172","author":"Han","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.critrevonc.2026.105415_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6870","article-title":"Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy","author":"Han","year":"2019","journal-title":"Sci. Adv. 5 eaaw6870."},{"key":"10.1016\/j.critrevonc.2026.105415_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12951-021-01110-0","article-title":"Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery","volume":"19","author":"Hao","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105415_bib30","doi-asserted-by":"crossref","first-page":"12499","DOI":"10.1038\/ncomms12499","article-title":"Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105415_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105415_bib32","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105415_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biomaterials.2018.11.021","article-title":"Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors","volume":"192","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105415_bib34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105415_bib35","article-title":"Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity","volume":"8","author":"Kokolus","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105415_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120395","article-title":"Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy","volume":"598","author":"Kunde","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105415_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41563-018-0093-6","article-title":"Dendritic cells in cancer immunotherapy","volume":"17","author":"Le Gall","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib38","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.apsb.2019.08.003","article-title":"Recent progress in drug delivery","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105415_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.apsb.2021.05.031","article-title":"Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105415_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12951-021-01095-w","article-title":"Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105415_bib41","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1021\/acsnano.8b00553","article-title":"Mesenchymal stem cell\/red blood cell-inspired nanoparticle therapy in mice with carbon tetrachloride-induced acute liver failure","volume":"12","author":"Liang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib42","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/D0NH00267D","article-title":"Biomimetic hybrid membrane-based nanoplatforms: synthesis, properties and biomedical applications","volume":"5","author":"Liao","year":"2020","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.critrevonc.2026.105415_bib43","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1038\/s41467-019-11157-1","article-title":"Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105415_bib44","article-title":"Expandable immunotherapeutic nanoplatforms engineered from cytomembranes of hybrid cells derived from cancer and dendritic cells","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40820-019-0330-9","article-title":"Cell membrane coating technology: a promising strategy for biomedical applications","volume":"11","author":"Liu","year":"2019","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.critrevonc.2026.105415_bib46","article-title":"Camouflaged hybrid cancer cell-platelet fusion membrane nanovesicles deliver therapeutic microRNAs to presensitize triple-negative breast cancer to doxorubicin","volume":"31","author":"Liu","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20240084","article-title":"Surface-anchored ticagrelor gelatin nanoparticles-platelets system for enhanced anti-PD-L1 therapy response and boosted chemotherapeutic efficacy of nanomedicines","volume":"5","author":"Lu","year":"2025","journal-title":"Exploration"},{"key":"10.1016\/j.critrevonc.2026.105415_bib48","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acsnano.8b00477","article-title":"Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib49","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acsnano.2c09033","article-title":"Tumor-antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib50","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105415_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib52","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2016.03.026","article-title":"Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy","volume":"92","author":"Ren","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105415_bib54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired resistance to immune checkpoint inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105415_bib55","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/ph15091059","article-title":"Hybrid membrane-derived nanoparticles for isoliquiritin enhanced glioma therapy","volume":"15","author":"Shi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.critrevonc.2026.105415_bib56","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105415_bib57","doi-asserted-by":"crossref","first-page":"eabl3649","DOI":"10.1126\/scitranslmed.abl3649","article-title":"Albumin nanoparticle containing a PI3K\u03b3 inhibitor and paclitaxel in combination with \u03b1-PD1 induces tumor remission of breast cancer in mice","volume":"14","author":"Song","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105415_bib58","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1002\/adfm.201603381","article-title":"Bioinspired nanoparticles with NIR-controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer","volume":"26","author":"Su","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib59","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.2147\/IJN.S266405","article-title":"Cancer cell-erythrocyte hybrid membrane coated gold nanocages for near infrared light-activated photothermal\/radio\/chemotherapy of breast cancer","volume":"15","author":"Sun","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.critrevonc.2026.105415_bib60","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105415_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ymeth.2012.01.002","article-title":"Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes","volume":"56","author":"Tauro","year":"2012","journal-title":"Methods"},{"key":"10.1016\/j.critrevonc.2026.105415_bib63","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.1714267114","article-title":"Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management","volume":"114","author":"Thamphiwatana","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105415_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201703197","article-title":"Cancer cell membrane-biomimetic oxygen nanocarrier for breaking hypoxia-induced chemoresistance","volume":"27","author":"Tian","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.critrevonc.2026.105415_bib66","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.addr.2016.02.007","article-title":"Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems","volume":"106","author":"Villa","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.critrevonc.2026.105415_bib67","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1021\/acsnano.7b08355","article-title":"Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal\/chemotherapy of melanoma","volume":"12","author":"Wang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121161","article-title":"Macrophage-derived implantable vaccine prevents postsurgical tumor recurrence","volume":"278","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105415_bib69","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1039\/D2BM01432G","article-title":"\u201cTrojan horse\u201d nanoparticle-delivered cancer cell membrane vaccines to enhance cancer immunotherapy by overcoming immune-escape","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.critrevonc.2026.105415_bib70","article-title":"Biomimetic nanoparticles facilitate homologous targeting and radiosensitivity in glioblastoma cells","volume":"32","author":"Wang","year":"2025","journal-title":"Mater. Today Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202000018","article-title":"Drug targeting via platelet membrane-coated nanoparticles","volume":"1","author":"Wang","year":"2020","journal-title":"Small Struct."},{"key":"10.1016\/j.critrevonc.2026.105415_bib72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acsnano.7b07720","article-title":"Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis","volume":"12","author":"Wei","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib73","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2018.12.019","article-title":"Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic","volume":"294","author":"Wu","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105415_bib74","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.2147\/IJN.S333279","article-title":"Platelet-tumor cell hybrid membrane-camouflaged nanoparticles for enhancing therapy efficacy in glioma","volume":"16","author":"Wu","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.critrevonc.2026.105415_bib75","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1039\/D0TB00735H","article-title":"Platelet membrane-coated nanoparticles for targeted drug delivery and local chemo-photothermal therapy of orthotopic hepatocellular carcinoma","volume":"8","author":"Wu","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.critrevonc.2026.105415_bib76","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105415_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111219","article-title":"Biomimetic hybrid-cell membrane nanoparticles loaded with panaxytriol for breast cancer combinational therapy","volume":"223","author":"Xie","year":"2022","journal-title":"Mater. Des."},{"key":"10.1016\/j.critrevonc.2026.105415_bib78","doi-asserted-by":"crossref","first-page":"19756","DOI":"10.1021\/acsnano.1c07180","article-title":"Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer","volume":"15","author":"Xiong","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105415_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12951-025-03165-9","article-title":"Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer","volume":"23","author":"Yao","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105415_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202300473","article-title":"Hybrid cell membrane-coated nanoparticles for biomedical applications","volume":"5","author":"Yu","year":"2024","journal-title":"Small Struct."},{"key":"10.1016\/j.critrevonc.2026.105415_bib81","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jconrel.2023.01.007","article-title":"A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors","volume":"354","author":"Zhang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105415_bib82","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1002\/smll.201500987","article-title":"Synthesis of nanogels via cell membrane-templated polymerization","volume":"11","author":"Zhang","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.critrevonc.2026.105415_bib83","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/anie.201500096","article-title":"Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents delivery","volume":"54","author":"Zhang","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.critrevonc.2026.105415_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202370371","article-title":"A Trojan-horse-like biomimetic nano-NK to elicit an immunostimulatory tumor microenvironment for enhanced GBM chemo-immunotherapy","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.critrevonc.2026.105415_bib85","article-title":"Development of a dendritic cell\/tumor cell fusion cell membrane nano-vaccine for the treatment of ovarian cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib86","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.2147\/IJN.S454004","article-title":"Advancements in stimulus-responsive co-delivery nanocarriers for enhanced cancer immunotherapy","volume":"19","author":"Zhang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.critrevonc.2026.105415_bib87","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105415_bib88","doi-asserted-by":"crossref","first-page":"31124","DOI":"10.1021\/acsami.8b11645","article-title":"C-C chemokine ligand 2 (CCL2) recruits macrophage-membrane-camouflaged hollow bismuth selenide nanoparticles to facilitate photothermal sensitivity and inhibit lung metastasis of breast cancer","volume":"10","author":"Zhao","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.critrevonc.2026.105415_bib89","doi-asserted-by":"crossref","first-page":"22843","DOI":"10.1021\/acsami.3c00469","article-title":"Long circulating cancer cell-targeted bionic nanocarriers enable synergistic combinatorial therapy in colon cancer","volume":"15","author":"Zheng","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.critrevonc.2026.105415_bib90","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1039\/D4NR00284A","article-title":"Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy","volume":"16","author":"Zhong","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.critrevonc.2026.105415_bib91","article-title":"Biomimetic nanotechnology toward personalized vaccines","volume":"32","author":"Zhou","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105415_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114367","article-title":"Enhancing TIM-3 immunotherapy with epirubicin-loaded pH sensitive fusion membrane nanoparticles for effective glioblastoma treatment","volume":"388","author":"Zhu","year":"2025","journal-title":"J. Control. Release"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:44:38Z","timestamp":1787107478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":92,"alternative-id":["S1040842826003021"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105415","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105415"}}